They do, but that spoils the fun of saying they’re desperately out of cash when in reality they’ve plenty to see them through this year. If you’re trolling it’s better to lie to ensure you get people to bite. Gotta earn those pennies when you’re not busy doing pizza deliveries. Simon has plenty time to get a deal over the line. If he gets sacked, then they’ll ask 🐶💩🪨🦷 for advice on a placing
Same is true for the vast majority Phil, including myself and especially at the moment as it's the annual funding trollfest.
Personally I'm here to provide ad revenue for LSE as their website is so terrible that half the time I try and click on a thread I get sent to buy some random Chinese tat
Alan has a disdain for AIM and PIs. It was shown by his snotty reaction when he was called out for saying no raise and then a matter of days later announcing one in 2020. I'd imagine he was quite happy being a lifestyle CEO pre covid, and I imagine he hates all the eyeballs on him - conversely, I'll bet he loved his trip to see Boris. He was probably hoping this share would be out of the limelight by now, unfortunately the science is looking incredible so he's stuck with the rabble and the scumbag city boys playing with his share price. Tis what it is.
DTW, I’ve been saying that for months. I don’t care about funding, they’ll get money one way or another. The ultimate success comes from the trial that continues. Double the shares in issue. If they get AVA6k to market there’s billions on the way. Almost ISA ‘top up’ time…
It won’t happen, phew nightmare over - just pointing out there’s more than one route to glory so who cares. The burn is about £1m a month. They’ll raise about 20m if they fail to sell the tech and boot the can down the road whilst the trial rumbles on. Licence deals are the plan and that should cover cash needs. We’ll see.
Hi Luke, picture the scene. It’s your worst nightmare. Massively dilutive funding. They’re going to double the number of shares in issue at 60p.. On the flip side, they’ll have about £180in the bank. They’ll pay off HCI and have wads of cash to see AVA6k through to a market worth billions. Turns out raising cash is a good thing. ‘Don’t worry about that, lolz’
Be more creative, once they’ve got more cash in the bank, what’s the next angle? Hardly a shock an early stage biotech needs cash. We know as Alan said during afternoon tea ‘don’t worry, lolz’. 20p placing inbound - then we can get back to talking about placebo smarties and the really dumb sh.t…